Ido(Paz-Priel)Paz PrielMD
Pediatric Hematology & Oncology • South San Francisco, CAAssistant Professor of Oncology, Johns Hopkins University School of Medicine; Pediatric Oncology Fellowship Director
Dr. Paz Priel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 DNA Way
South San Francisco, CA 94080Phone+1 650-219-4453
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Maimonides Medical Center/Infants and Children's Hospital of BrooklynResidency, Pediatrics, 1999 - 2002
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1992
Certifications & Licensure
MD State Medical License 2002 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 92 citationsEffects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation AssaysJoanne I. Adamkewicz, David Chen, Ido Paz-Priel
Thrombosis and Haemostasis. 2019-05-07 - 40 citationsC/EBPα dysregulation in AML and ALL.Ido Paz-Priel, Alan D. Friedman
Critical Reviews in Oncogenesis. 2011-01-01 - 6 citationsCrovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.Jun-Ichi Nishimura, Kensuke Usuki, Julia Ramos, Satoshi Ichikawa, Muriel Buri
British Journal of Haematology. 2022-08-01
Other Languages
- Hebrew
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ido-paz-priel
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
